FilingReader Intelligence
Kangmei subsidiary settles RMB 43.5m debt with related party
July 17, 2025 at 08:09 AM UTC•By FilingReader AI
Kangmei Pharmaceutical's subsidiary Chengdu Kangmei will settle RMB 43.5 million in debt plus related fees with Guangzhou Pharmaceutical Group.
The agreement resolves historical debt of RMB 49.39 million that was previously secured by Chengdu Kangmei's assets, allowing enforcement measures to be lifted.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600518•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Kangmei Pharmaceutical publishes news
Free account required • Unsubscribe anytime